Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.06 | - |
NAV | ₹20.69 | - |
Fund Started | 06 Oct 2020 | - |
Fund Size | ₹170.77 Cr | - |
Exit Load | - | - |
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.06
-
NAV
₹20.69
-
Fund Started
06 Oct 2020
-
Fund Size
₹170.77 Cr
-
Exit Load
-
-
1 Year | 9.30% | - |
3 Year | 19.17% | - |
5 Year | 13.04% | - |
1 Year
9.30%
-
3 Year
19.17%
-
5 Year
13.04%
-
Equity | 99.94% | - |
Cash | -0.10% | - |
Equity
99.94%
-
Cash
-0.10%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.98% |
Eli Lilly And Co | 6.97% |
Cipla Ltd. | 5.69% |
Max Healthcare Institute Ltd. | 5.41% |
Divi's Laboratories Ltd. | 5.08% |
Apollo Hospitals Enterprise Ltd. | 5.05% |
Dr. Reddy's Laboratories Ltd. | 4.59% |
Johnson & Johnson Ltd. | 4.02% |
Lupin Ltd. | 3.53% |
AbbVie Inc | 3.25% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | - |
Launch Date | 06 Oct 2020 | - |
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
-
Launch Date
06 Oct 2020
-